VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models
Open Access
- 1 October 2019
- Vol. 21 (10) , 1036-1050
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapyProceedings of the National Academy of Sciences, 2012
- Molecular MRI enables early and sensitive detection of brain metastasesProceedings of the National Academy of Sciences, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- In Vivo Quantification of Vcam-1 Expression in Renal Ischemia Reperfusion Injury Using Non-Invasive Magnetic Resonance Molecular ImagingPLOS ONE, 2010
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of CancerCancer Research, 2010
- In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxideNature Medicine, 2007
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding RadioligandsJournal of Cerebral Blood Flow & Metabolism, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Rules of Recruitment for Th1 and Th2 Lymphocytes in Inflamed Liver: A Role for Alpha-4 Integrin and Vascular Adhesion Protein-1Immunity, 2005